The Valens Company Inc (TSE:VLNS) (OTCQX:VLNCF) (FRA:7LV) announced it has joined the Cannabis Council of Canada (C3), a national membership organization representing Canadian cannabis producers and processors licensed under the Cannabis Act.
Valens said as a C3 member, it looks forward to contributing to a variety of initiatives geared toward shaping the growth of the legal cannabis industry and its commitment to protecting public health and safety.
“C3 shares the same passion for bringing the benefits of regulated and legal cannabis to Canadians as we do, and we have long admired their efforts to create and uphold the highest standards for the industry,” The Valens Company CEO Tyler Robson said in a statement.
READ: The Valens Company increases its addressable market in Canada with launch of several new products
“We look forward to working alongside our peers and sector leaders to influence and contribute to some of the most pressing matters facing Canada's legal cannabis industry,” Robson added.
Cannabis Council of Canada CEO George Smitherman also commented, stating: “Valens is an established cannabis industry leader whose commitment to product safety and innovation are making an important contribution to the success of Canada's legal cannabis industry.”
“Their experience, expertise and industry relationships are welcome assets in support of C3's ongoing advocacy and regulatory efforts.”
Valens noted it expects to participate in C3's established caucuses and committees, including those working on vape product safety standards and the taxation of cannabis vaping products, as well as playing a role in expanding C3's national vape recycling program.
The Cannabis Council of Canada's current efforts are focused on the legal industry's ability to create jobs, growth and progress, through the elimination of the excise tax on medical cannabis, reform of the cannabis beverage equivalency formula, as well as expungement of criminal records for minor cannabis convictions, amongst other initiatives.
The Valens Company's products are exclusively formulated for the medical, therapeutic, health and wellness, and recreational segments, and are offered across numerous formats, including oils, vapes, concentrates, edibles and topicals, as well as pre-rolls.
Via its wholly-owned subsidiary Valens Labs Ltd, the company also has Canada's only ISO17025 accredited analytical services lab, named The Centre of Excellence in Plant-Based Science by partner and scientific world leader Thermo Fisher Scientific.
Contact Sean at sean@proactiveinvestors.com